Send to

Choose Destination
Blood. 2019 May 9;133(19):2003-2004. doi: 10.1182/blood-2019-03-901090.

Ibrutinib: the home run for cure in CLL?

Author information

Ludwig-Maximilians University; University of Cologne.

Conflict of interest statement

Conflict-of-interest disclosure: C.-M.W. reported research funding and/or honoraria for a consultancy/advisory role from Hoffmann-La Roche, Janssen, AbbVie, Gilead, Celgene, Novartis, MorphoSys, and AstraZeneca.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center